StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

PRAXBullishAnalyst Target Updateanalyst
High materiality7/10

Wells Fargo Upgrades Praxis Precision Medicines to Overweight

Nov 17, 2026, 3:05 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Bullish analyst view; the target is an estimate, not a guaranteed return.

AI summary

What happened, with direct paths to the underlying reporting

Wells Fargo upgraded PRAX to Overweight and set a $509 target, about 64% above the posted price of $310.27.

  • Wells Fargo upgraded PRAX to Overweight.
  • The $509 target is about 64% above the posted price.

Key facts

  1. 01

    Target: $509

  2. 02

    Posted price: $310.27

  3. 03

    Analyst firm: Wells Fargo

  4. 04

    Analyst: Ben Burnett

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.